Jazz Exec Bruce Cozadd Sells 6,000 Shares in Routine Rule‑10b‑5 Trade Amid Bull‑Market Rally
Jazz Pharmaceuticals insider sale shows disciplined, rule‑compliant trading—not a bearish warning—while the company’s strong pipeline and earnings keep investors optimistic.
3 minutes to read